Rohan Bir Singh, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dry Eye Syndromes | 10 | 2024 | 383 | 2.950 |
Why?
|
Corneal Ulcer | 5 | 2024 | 125 | 2.860 |
Why?
|
Corneal Perforation | 6 | 2022 | 28 | 2.630 |
Why?
|
Keratoconus | 3 | 2024 | 112 | 2.390 |
Why?
|
Keratitis, Herpetic | 3 | 2023 | 76 | 2.180 |
Why?
|
Keratitis | 5 | 2022 | 241 | 2.030 |
Why?
|
Corneal Transplantation | 5 | 2024 | 315 | 1.700 |
Why?
|
Uveitis | 4 | 2023 | 398 | 1.470 |
Why?
|
Conjunctivitis | 2 | 2021 | 153 | 1.360 |
Why?
|
Hyperemia | 2 | 2021 | 224 | 1.350 |
Why?
|
Corneal Diseases | 4 | 2024 | 535 | 1.330 |
Why?
|
Glaucoma | 3 | 2023 | 1194 | 1.160 |
Why?
|
Cornea | 11 | 2024 | 1314 | 1.150 |
Why?
|
Corneal Dystrophies, Hereditary | 3 | 2022 | 62 | 1.120 |
Why?
|
Retinal Diseases | 4 | 2024 | 710 | 1.110 |
Why?
|
Visual Acuity | 4 | 2024 | 2714 | 1.020 |
Why?
|
Keratoplasty, Penetrating | 2 | 2023 | 143 | 0.990 |
Why?
|
Eye Injuries | 2 | 2018 | 227 | 0.990 |
Why?
|
Fuchs' Endothelial Dystrophy | 2 | 2024 | 103 | 0.960 |
Why?
|
Graft vs Host Disease | 6 | 2024 | 3044 | 0.960 |
Why?
|
Macular Degeneration | 3 | 2024 | 1016 | 0.960 |
Why?
|
Cataract | 2 | 2022 | 837 | 0.930 |
Why?
|
Corneal Opacity | 1 | 2024 | 52 | 0.910 |
Why?
|
Uveitis, Posterior | 2 | 2023 | 45 | 0.900 |
Why?
|
Vaccines | 2 | 2023 | 842 | 0.900 |
Why?
|
Choroiditis | 1 | 2022 | 12 | 0.830 |
Why?
|
Herpes Zoster Ophthalmicus | 1 | 2023 | 37 | 0.830 |
Why?
|
Serpins | 2 | 2021 | 245 | 0.800 |
Why?
|
Central Serous Chorioretinopathy | 1 | 2022 | 32 | 0.790 |
Why?
|
Academies and Institutes | 1 | 2024 | 326 | 0.780 |
Why?
|
Tissue Adhesives | 2 | 2020 | 179 | 0.770 |
Why?
|
Descemet Stripping Endothelial Keratoplasty | 1 | 2023 | 110 | 0.760 |
Why?
|
Lacrimal Apparatus | 2 | 2021 | 223 | 0.760 |
Why?
|
Th17 Cells | 4 | 2024 | 791 | 0.750 |
Why?
|
Nerve Growth Factors | 2 | 2021 | 564 | 0.730 |
Why?
|
Graft Rejection | 3 | 2024 | 4505 | 0.720 |
Why?
|
Eye Diseases | 2 | 2024 | 657 | 0.720 |
Why?
|
Ophthalmology | 2 | 2024 | 560 | 0.700 |
Why?
|
Eye Proteins | 2 | 2021 | 628 | 0.700 |
Why?
|
Neuronal Ceroid-Lipofuscinoses | 1 | 2021 | 134 | 0.690 |
Why?
|
Paraproteinemias | 1 | 2023 | 252 | 0.690 |
Why?
|
Ultraviolet Rays | 3 | 2024 | 1100 | 0.680 |
Why?
|
Cost of Illness | 3 | 2024 | 1959 | 0.660 |
Why?
|
Herpes Simplex | 1 | 2023 | 470 | 0.650 |
Why?
|
Ichthyosiform Erythroderma, Congenital | 1 | 2018 | 7 | 0.640 |
Why?
|
Oculomotor Nerve Diseases | 1 | 2019 | 53 | 0.630 |
Why?
|
Acanthamoeba Keratitis | 1 | 2018 | 14 | 0.630 |
Why?
|
Amebiasis | 1 | 2018 | 33 | 0.630 |
Why?
|
Eye Infections, Bacterial | 1 | 2021 | 239 | 0.620 |
Why?
|
Optic Nerve Neoplasms | 1 | 2018 | 45 | 0.590 |
Why?
|
Lighting | 1 | 2020 | 210 | 0.590 |
Why?
|
Glaucoma Drainage Implants | 1 | 2018 | 107 | 0.550 |
Why?
|
Eye Infections, Fungal | 1 | 2018 | 99 | 0.550 |
Why?
|
Sclera | 1 | 2018 | 189 | 0.550 |
Why?
|
T-Lymphocytes, Regulatory | 5 | 2024 | 3112 | 0.540 |
Why?
|
Glaucoma, Open-Angle | 1 | 2022 | 742 | 0.520 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2024 | 5713 | 0.500 |
Why?
|
Eye | 4 | 2023 | 712 | 0.470 |
Why?
|
Diabetic Retinopathy | 2 | 2024 | 1299 | 0.450 |
Why?
|
alpha-MSH | 2 | 2024 | 71 | 0.440 |
Why?
|
Health Care Costs | 2 | 2023 | 3267 | 0.440 |
Why?
|
Corneal Edema | 2 | 2024 | 45 | 0.430 |
Why?
|
Cardiovascular System | 1 | 2020 | 838 | 0.410 |
Why?
|
Radiation Injuries | 1 | 2020 | 1204 | 0.400 |
Why?
|
Choroid | 4 | 2023 | 363 | 0.400 |
Why?
|
Humans | 60 | 2024 | 768393 | 0.380 |
Why?
|
Anti-Inflammatory Agents | 1 | 2021 | 1813 | 0.370 |
Why?
|
Trigeminal Nerve Diseases | 2 | 2022 | 48 | 0.370 |
Why?
|
Receptors, Neurokinin-1 | 2 | 2022 | 133 | 0.360 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2018 | 1376 | 0.350 |
Why?
|
Neoplasms, Second Primary | 1 | 2018 | 1060 | 0.340 |
Why?
|
Cyanoacrylates | 2 | 2020 | 47 | 0.340 |
Why?
|
Anesthesia | 1 | 2021 | 1596 | 0.330 |
Why?
|
Adverse Drug Reaction Reporting Systems | 2 | 2023 | 495 | 0.330 |
Why?
|
Occupational Exposure | 1 | 2020 | 1817 | 0.330 |
Why?
|
Disease Models, Animal | 6 | 2024 | 18362 | 0.310 |
Why?
|
Pandemics | 3 | 2024 | 8753 | 0.310 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3118 | 0.310 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3241 | 0.300 |
Why?
|
Prevalence | 7 | 2024 | 15872 | 0.300 |
Why?
|
Registries | 1 | 2024 | 8379 | 0.300 |
Why?
|
Trabeculectomy | 2 | 2020 | 174 | 0.290 |
Why?
|
Conjunctiva | 2 | 2021 | 474 | 0.290 |
Why?
|
Retrospective Studies | 13 | 2024 | 81801 | 0.280 |
Why?
|
Vaccination | 3 | 2023 | 3431 | 0.270 |
Why?
|
Mice, Inbred C57BL | 6 | 2024 | 22355 | 0.250 |
Why?
|
India | 3 | 2021 | 2325 | 0.250 |
Why?
|
Tomography, Optical Coherence | 4 | 2023 | 2957 | 0.250 |
Why?
|
Medicare | 1 | 2023 | 6881 | 0.240 |
Why?
|
Corneal Topography | 1 | 2024 | 69 | 0.230 |
Why?
|
Intraocular Pressure | 2 | 2022 | 1304 | 0.230 |
Why?
|
Fluorescein Angiography | 4 | 2023 | 1086 | 0.230 |
Why?
|
Integrin alpha Chains | 1 | 2024 | 93 | 0.230 |
Why?
|
Middle Aged | 16 | 2024 | 223491 | 0.230 |
Why?
|
Antigen-Presenting Cells | 3 | 2024 | 962 | 0.230 |
Why?
|
Female | 25 | 2024 | 397089 | 0.220 |
Why?
|
Communicable Disease Control | 1 | 2020 | 857 | 0.220 |
Why?
|
Vision Disorders | 2 | 2021 | 1093 | 0.220 |
Why?
|
Eye Pain | 2 | 2022 | 46 | 0.220 |
Why?
|
Male | 20 | 2024 | 364902 | 0.220 |
Why?
|
Contact Lenses | 1 | 2024 | 137 | 0.210 |
Why?
|
Palliative Care | 1 | 2018 | 3643 | 0.210 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5512 | 0.200 |
Why?
|
Adult | 15 | 2024 | 223640 | 0.200 |
Why?
|
Tears | 2 | 2022 | 252 | 0.200 |
Why?
|
Vision Tests | 1 | 2022 | 160 | 0.200 |
Why?
|
Endothelium, Corneal | 1 | 2024 | 212 | 0.200 |
Why?
|
Biology | 1 | 2024 | 292 | 0.190 |
Why?
|
Aged | 12 | 2024 | 171562 | 0.190 |
Why?
|
Epithelium, Corneal | 2 | 2022 | 247 | 0.190 |
Why?
|
Dendritic Cells | 2 | 2024 | 2749 | 0.190 |
Why?
|
Schools | 2 | 2021 | 1496 | 0.190 |
Why?
|
Substance P | 1 | 2022 | 332 | 0.180 |
Why?
|
Contrast Sensitivity | 1 | 2022 | 253 | 0.180 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2022 | 125 | 0.180 |
Why?
|
Electrocoagulation | 1 | 2021 | 153 | 0.180 |
Why?
|
Corneal Neovascularization | 1 | 2022 | 184 | 0.170 |
Why?
|
Immune Evasion | 1 | 2024 | 376 | 0.170 |
Why?
|
Timolol | 1 | 2020 | 51 | 0.170 |
Why?
|
Aged, 80 and over | 8 | 2024 | 59686 | 0.170 |
Why?
|
Ophthalmic Solutions | 1 | 2021 | 312 | 0.170 |
Why?
|
Th1 Cells | 1 | 2024 | 1042 | 0.160 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2024 | 12241 | 0.160 |
Why?
|
Asthenopia | 1 | 2019 | 12 | 0.160 |
Why?
|
Photophobia | 1 | 2020 | 77 | 0.160 |
Why?
|
Intestinal Perforation | 1 | 2021 | 253 | 0.160 |
Why?
|
Acanthamoeba | 1 | 2018 | 12 | 0.160 |
Why?
|
Visual Field Tests | 1 | 2021 | 415 | 0.160 |
Why?
|
Diabetic Ketoacidosis | 1 | 2022 | 255 | 0.160 |
Why?
|
Early Diagnosis | 1 | 2024 | 1195 | 0.160 |
Why?
|
United States | 5 | 2024 | 73150 | 0.150 |
Why?
|
Interleukin-1 | 1 | 2022 | 1251 | 0.150 |
Why?
|
Sex Distribution | 1 | 2023 | 2281 | 0.150 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2024 | 3440 | 0.150 |
Why?
|
Blepharoptosis | 1 | 2019 | 145 | 0.150 |
Why?
|
Diplopia | 1 | 2019 | 217 | 0.150 |
Why?
|
Age Distribution | 1 | 2023 | 2877 | 0.150 |
Why?
|
Dwarfism | 1 | 2018 | 137 | 0.150 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2021 | 354 | 0.150 |
Why?
|
Thrombospondin 1 | 1 | 2019 | 257 | 0.140 |
Why?
|
Animals | 16 | 2024 | 169337 | 0.140 |
Why?
|
Mice | 13 | 2024 | 82017 | 0.140 |
Why?
|
Anterior Chamber | 1 | 2018 | 194 | 0.140 |
Why?
|
Computers, Handheld | 1 | 2019 | 211 | 0.140 |
Why?
|
Forkhead Transcription Factors | 1 | 2024 | 1623 | 0.140 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2023 | 1122 | 0.140 |
Why?
|
Flow Cytometry | 2 | 2024 | 5900 | 0.140 |
Why?
|
Graft Survival | 2 | 2024 | 3900 | 0.130 |
Why?
|
Collagen | 1 | 2024 | 2646 | 0.130 |
Why?
|
Intravitreal Injections | 1 | 2018 | 401 | 0.130 |
Why?
|
Terminally Ill | 1 | 2018 | 240 | 0.130 |
Why?
|
Lysosomes | 1 | 2021 | 939 | 0.130 |
Why?
|
Educational Status | 1 | 2023 | 2518 | 0.120 |
Why?
|
Reading | 1 | 2019 | 543 | 0.120 |
Why?
|
Simplexvirus | 1 | 2018 | 805 | 0.120 |
Why?
|
Databases, Factual | 1 | 2020 | 8075 | 0.120 |
Why?
|
DNA Damage | 1 | 2024 | 2458 | 0.120 |
Why?
|
Optic Nerve | 1 | 2018 | 571 | 0.120 |
Why?
|
Glucocorticoids | 1 | 2024 | 2168 | 0.120 |
Why?
|
Interleukin-6 | 1 | 2024 | 3230 | 0.110 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15649 | 0.110 |
Why?
|
Antigens, CD | 1 | 2024 | 4031 | 0.110 |
Why?
|
Health Resources | 1 | 2020 | 950 | 0.110 |
Why?
|
Drug Combinations | 1 | 2020 | 2079 | 0.110 |
Why?
|
Streptozocin | 2 | 2024 | 190 | 0.110 |
Why?
|
Fatal Outcome | 1 | 2018 | 1837 | 0.110 |
Why?
|
Oxidative Stress | 1 | 2024 | 3139 | 0.110 |
Why?
|
Antihypertensive Agents | 1 | 2022 | 2027 | 0.100 |
Why?
|
Analgesics | 1 | 2020 | 1070 | 0.100 |
Why?
|
Young Adult | 5 | 2024 | 60049 | 0.100 |
Why?
|
Artificial Intelligence | 2 | 2024 | 2661 | 0.100 |
Why?
|
Child | 4 | 2024 | 80891 | 0.090 |
Why?
|
Extracellular Matrix | 1 | 2019 | 1739 | 0.090 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1890 | 0.090 |
Why?
|
Cytokines | 3 | 2021 | 7445 | 0.090 |
Why?
|
Neoplasms | 1 | 2020 | 22385 | 0.090 |
Why?
|
Adolescent | 5 | 2024 | 89184 | 0.090 |
Why?
|
Treatment Outcome | 4 | 2023 | 65379 | 0.090 |
Why?
|
Internet | 1 | 2023 | 3107 | 0.090 |
Why?
|
Bacteria | 1 | 2021 | 2221 | 0.090 |
Why?
|
Disease Progression | 2 | 2024 | 13646 | 0.090 |
Why?
|
Public Health | 1 | 2024 | 2682 | 0.090 |
Why?
|
Gene Expression | 1 | 2022 | 7598 | 0.080 |
Why?
|
Retina | 1 | 2020 | 2661 | 0.080 |
Why?
|
Interleukin-10 | 2 | 2024 | 1184 | 0.080 |
Why?
|
Child, Preschool | 2 | 2024 | 42650 | 0.080 |
Why?
|
Epithelial Cells | 1 | 2020 | 3695 | 0.070 |
Why?
|
Reproducibility of Results | 2 | 2023 | 20224 | 0.070 |
Why?
|
Autoimmune Diseases | 1 | 2020 | 2257 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2020 | 4209 | 0.070 |
Why?
|
Wound Healing | 3 | 2023 | 2813 | 0.070 |
Why?
|
Phenotype | 2 | 2024 | 16721 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2022 | 4365 | 0.070 |
Why?
|
Anxiety | 1 | 2021 | 4677 | 0.060 |
Why?
|
Antiviral Agents | 1 | 2018 | 3064 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2021 | 4069 | 0.060 |
Why?
|
Mice, Inbred BALB C | 2 | 2024 | 6234 | 0.060 |
Why?
|
Inflammation | 2 | 2022 | 10863 | 0.060 |
Why?
|
Desiccation | 1 | 2024 | 77 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 26375 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 13020 | 0.060 |
Why?
|
Risk Factors | 4 | 2024 | 74962 | 0.060 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2024 | 306 | 0.050 |
Why?
|
Tissue Preservation | 1 | 2023 | 173 | 0.050 |
Why?
|
Cytoprotection | 1 | 2023 | 200 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5375 | 0.050 |
Why?
|
Adoptive Transfer | 1 | 2024 | 824 | 0.050 |
Why?
|
Infant | 1 | 2024 | 36510 | 0.050 |
Why?
|
Fluorescein | 1 | 2022 | 175 | 0.050 |
Why?
|
Fluorophotometry | 1 | 2021 | 40 | 0.050 |
Why?
|
Keratoconjunctivitis Sicca | 1 | 2021 | 26 | 0.050 |
Why?
|
Postoperative Complications | 1 | 2023 | 15881 | 0.050 |
Why?
|
Fundus Oculi | 1 | 2023 | 560 | 0.050 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2024 | 328 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6971 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 2 | 2019 | 36849 | 0.050 |
Why?
|
Neutrophil Infiltration | 1 | 2023 | 395 | 0.050 |
Why?
|
Hydrogen Peroxide | 1 | 2024 | 742 | 0.040 |
Why?
|
Colon, Sigmoid | 1 | 2021 | 124 | 0.040 |
Why?
|
Indocyanine Green | 1 | 2022 | 239 | 0.040 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2024 | 637 | 0.040 |
Why?
|
Coculture Techniques | 1 | 2024 | 1342 | 0.040 |
Why?
|
Immunomodulation | 1 | 2024 | 549 | 0.040 |
Why?
|
Cell Line | 2 | 2024 | 15597 | 0.040 |
Why?
|
Time Factors | 1 | 2021 | 40272 | 0.040 |
Why?
|
Renin-Angiotensin System | 1 | 2024 | 739 | 0.040 |
Why?
|
Mutation | 1 | 2024 | 30228 | 0.040 |
Why?
|
Cells, Cultured | 2 | 2024 | 19022 | 0.040 |
Why?
|
Immune System | 1 | 2024 | 801 | 0.040 |
Why?
|
Photography | 1 | 2020 | 537 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11854 | 0.030 |
Why?
|
Quality of Life | 1 | 2018 | 13503 | 0.030 |
Why?
|
Pilot Projects | 2 | 2020 | 8731 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20765 | 0.030 |
Why?
|
Chronic Disease | 2 | 2021 | 9379 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2024 | 2324 | 0.030 |
Why?
|
Monocytes | 1 | 2023 | 2595 | 0.030 |
Why?
|
Cell Movement | 1 | 2024 | 5215 | 0.030 |
Why?
|
Angiogenesis Inhibitors | 1 | 2022 | 2060 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2022 | 3520 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2023 | 3587 | 0.020 |
Why?
|
Macrophages | 1 | 2023 | 5796 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9261 | 0.020 |
Why?
|
Logistic Models | 1 | 2019 | 13323 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2020 | 11668 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 30200 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39407 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 54920 | 0.010 |
Why?
|